Applied DNA Sciences Inc. (NASDAQ:APDN) shares fell to a low of $10.8583 before closing at $11.14. Intraday shares traded counted 0.39 million, which was 73.23% higher than its 30-day average trading volume of 1.46M. APDN’s previous close was $10.75 while the outstanding shares total 7.47M. The firm has a beta of 1.16. The stock’s Relative Strength Index (RSI) is 54.52, with weekly volatility at 8.52% and ATR at 1.23. The APDN stock’s 52-week price range has touched low of $2.52 and a $16.39 high. The stock traded higher over the last trading session, gaining 3.63% on 02/19/21.
Investors have identified the Security & Protection Services company Applied DNA Sciences Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $80.32 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Applied DNA Sciences Inc. (APDN) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 6.54 million total, with 2.92 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 0.63 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on APDN sounds very interesting.
Is the stock of APDN attractive?
In related news, ex 5% owner, Montgomery William W bought 110,000 shares of the company’s stock in a transaction that recorded on Jun 26. The purchase was performed at an average price of 5.25, for a total value of 577,500. As the purchase deal closes, the 5% owner, Montgomery William W now bought 40,000 shares of the company’s stock, valued at 210,000. Also, 5% Owner, Montgomery William W bought 75,000 shares of the company’s stock in a deal that was recorded on Jun 09. The shares were cost at an average price of 5.25 per share, with a total market value of 393,750. In the last 6 months, insiders have changed their ownership in shares of company stock by 13.83%.
3 out of 3 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on Applied DNA Sciences Inc.. 0 analysts has assigned a Sell rating on the APDN stock. The 12-month mean consensus price target for the company’s shares has been set at $18.67.